After a two‑level anterior cervical discectomy and fusion (ACDF), is arm tingling or burning considered a sensory deficit?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Arm Tingling or Burning as Sensory Deficit After ACDF

Yes, arm tingling or burning is definitively considered a sensory deficit in the context of post-ACDF evaluation and represents a clinically significant neurological finding that warrants documentation and monitoring. 1

Clinical Classification of Sensory Deficits

Sensory deficits after ACDF encompass a spectrum of abnormal sensory phenomena, including:

  • Paresthesias (tingling, burning sensations) are explicitly classified as sensory deficits and represent incomplete recovery or new-onset neurological changes following cervical decompression 2, 3
  • Dermatomal sensory changes, including altered sensation, numbness, and dysesthesias, all fall under the category of sensory dysfunction in cervical radiculopathy 1
  • The distinction between "positive" symptoms (tingling, burning) and "negative" symptoms (numbness) is clinically irrelevant—both represent sensory pathway dysfunction 1

Natural History of Sensory Recovery After ACDF

Understanding the expected recovery pattern is critical for interpreting postoperative sensory symptoms:

  • 85% of patients with preoperative sensory deficits recover within the first year after ACDF, making early postoperative paresthesias a common and often transient finding 2
  • However, 30% of patients develop new sensory deficits after ACDF by final follow-up, with 60% of these occurring at adjacent levels rather than the operated level 2
  • Patients with preoperative sensory deficits are more likely to develop new postoperative sensory deficits (p=0.05), suggesting underlying neural vulnerability 2

Documentation and Clinical Significance

When evaluating arm tingling or burning after ACDF, the following framework should guide assessment:

  • Document the specific dermatomal distribution to determine whether symptoms correspond to the operated level or suggest adjacent-level pathology 1, 2
  • Assess timing of symptom onset: immediate postoperative symptoms may represent surgical manipulation or reperfusion injury, while delayed symptoms suggest progressive pathology 4, 5
  • Grade severity and functional impact: mild paresthesias without motor deficit carry different prognostic implications than progressive sensory loss with weakness 3

Critical Distinction: Benign vs. Concerning Sensory Deficits

Not all postoperative sensory deficits warrant the same level of concern:

  • Isolated mild paresthesias with improving trajectory represent expected recovery patterns in most patients and do not require urgent intervention 2, 3
  • Progressive or severe sensory deficits, especially when accompanied by motor weakness or myelopathic signs, mandate urgent MRI to exclude epidural hematoma, cord compression, or white cord syndrome 4, 5
  • The presence of T1 dermatomal paresthesias specifically may indicate lower cervical nerve root involvement and should be correlated with surgical levels 4

Common Pitfalls in Interpretation

Avoid these errors when evaluating postoperative sensory symptoms:

  • Do not dismiss paresthesias as "normal postoperative findings" without proper neurological examination, as they may herald more serious complications 4, 5
  • Do not attribute all sensory deficits to surgical edema or manipulation without considering reperfusion injury, ongoing compression, or adjacent-level disease 4, 5
  • Do not fail to obtain urgent MRI when sensory deficits are progressive or associated with motor changes, as delayed recognition of white cord syndrome or epidural hematoma can result in permanent neurological injury 4, 5

Outcome Implications

The presence and resolution of sensory deficits directly impacts patient satisfaction and functional outcomes:

  • Pain relief is the primary driver of patient satisfaction after ACDF (p=0.001), while sensory function improvement shows weaker correlation (p=0.225) 6
  • Despite this, 83% of patients with preoperative paresthesias report improvement at discharge, indicating that sensory recovery remains a meaningful outcome measure 3
  • Motor recovery occurs in 95% of patients within one year, suggesting that isolated sensory deficits without motor involvement carry favorable prognosis 2

References

1
Guideline

Cervical Radiculopathy Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4
Research

Major neurological deficit following anterior cervical decompression and fusion: what is the next step?

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2015

Related Questions

What is the treatment for cervical cord compression?
When is cervical intervertebral disc protrusion concerning?
What is the differential diagnosis and management for a patient with a history of forearm trauma presenting with acute neurological deficit and normal brain and cervical spine MRI?
Can meningeal tethering after anterior cervical disc (ACD) decompression surgery cause strange paresthesias in the long post-operative period?
What are the activity limitations and post-operative instructions for a patient after Anterior Cervical Discectomy and Fusion (ACDF) surgery?
In grade III hepatic encephalopathy, does giving lactulose 30 ml orally every 2 hours improve outcomes compared with dosing lactulose four times daily?
In a 60‑year‑old with recent mid‑ to lower‑back pain, hyperesthesia, progressive weakness and numbness in the extremities, and abdominal bloating, what is the most likely diagnosis and immediate management?
For an adult starting Qelbree (viloxazine extended‑release) on the standard titration schedule, how many capsules are required for a 30‑day month?
In a patient with a 7 mm solid hypoechoic non‑functioning thyroid nodule, a history of Graves disease treated with radioactive iodine and on levothyroxine, could the nodule make it difficult to keep thyroid‑stimulating hormone within target despite careful dose adjustments?
What is the appropriate initial non‑operative management for a patient with a partial bowel obstruction?
How are topical corticosteroids classified by potency and what are example agents for each potency category?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question